#None #Healthcare Market #POC Diagnostics #Kalorama Information

Latest Insights into the Global Point-of-Care Diagnostics Market

Kalorama Information recently published its 12th edition of the Worldwide Market for Point-of-Care Diagnostic Tests, revealing intriguing insights into the fast-evolving sector. The report indicates that the global market for point-of-care (POC) diagnostics has crossed the remarkable threshold of $36 billion in 2024, reflecting a strong demand that is anticipated to maintain steady growth through 2029. This expansion is primarily attributed to an aging population, increasing disease prevalence, and significant advancements in technology.

A Transforming Market Landscape

POC diagnostics have transformed from being a niche segment to a fundamental component of modern healthcare. Melissa Elder, a Senior Analyst at Kalorama Information, emphasized this evolution by stating, "POC testing is no longer a fringe segment—it is a central pillar of modern diagnostics." Companies at the forefront of this transformation include notable names like Abbott, Dexcom, Roche, Danaher, and Exact Sciences, all of which are heavily investing in innovation and development of POC solutions for various medical needs including blood gases, infectious diseases, and glucose monitoring.

Key Growth Drivers

A deeper look into the report highlights several factors propelling the growth of the POC diagnostics sector:

• - Growing Revenues: The report states that the POC market is cruising along a mid-single-digit compound annual growth rate (CAGR) through 2029, bolstered by significant sales in physician offices, clinics, and mobile care platforms.
• - High-Impact Segments: High-growth markets include oncology, stroke, dementia, cardiac markers, and glucose monitoring—especially driven by the continuous glucose monitoring (CGM) trend.
• - Technological Advancements: Innovations in CRISPR virus detection, biosensors, lab-on-a-chip technologies, and AI-driven testing solutions are altering the capabilities of point-of-care diagnostics significantly.
• - Molecular POC Diagnostics: Originating from the urgent responses during the COVID-19 crisis, rapid molecular diagnostics have found their place in emergency care and field screenings across various settings in both developed and developing nations.
• - Consumer-Driven Health Management: The rise of wearable and Bluetooth-enabled devices enables patients to engage in live health tracking and proactive health management actively.

Addressing Market Uncertainties

The report also aids stakeholders—product developers, investors, and strategic planners—by clarifying various aspects of the diagnostics market landscape:
1. Regional and Test Category Growth: Identifying regions and test categories experiencing the fastest growth rates.
2. Impact of Pricing Pressures: Understanding how ongoing pricing pressures and changes post-COVID influence product demand.
3. New Technological Trends: Spotting emerging technologies that redefine diagnostic availability and precision.
4. Regulatory Influences: Analyzing how regulatory frameworks shape go-to-market strategies in this dynamic environment.

Market Leaders and Their Impacts

Abbott is recognized as a market leader with over 25% share, primarily due to its diverse portfolio of POC tests covering areas such as cardiac markers, drugs of abuse, infectious diseases, and lipid testing. Other industry players like Dexcom and Roche have solidified their respective positions in niches such as CGM and coagulation testing, highlighting a competitive landscape with Exact Sciences making notable strides in colon cancer testing. Furthermore, Danaher’s Beckman Coulter unit remains instrumental in the fields of blood, cancer, and infectious disease diagnostics.

Essential Resource for Industry Players

The 12th edition of this landmark report offers:

• - Market Size and Forecasts until 2029: Comprehensive predictions and analysis.
• - Enhanced Segmentation: More than 10 test types analyzed in detail.
• - Venue Analysis: Evaluative insights across hospitals, clinics, retail, and home.
• - Competitive Profiles: Valuable regulatory trend insights and competitive profiling to understand market dynamics.

Developed by seasoned diagnostics analysts with over 25 years of collective experience, this report synthesizes findings from extensive primary and secondary research efforts.
For further consumption, the report titled Worldwide Market for Point-of-Care Diagnostic Tests, 12th Edition can be explored and purchased through the Kalorama Information official site.

For inquiries regarding custom consultations or additional resources, contact Kalorama Information’s sales director.

As a part of the Science and Medicine Group, Kalorama Information remains dedicated to providing actionable insights crucial for healthcare companies, investors, and institutions around the world, thereby bolstering informed decision-making processes.